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ABSTRACT 
 
Lymphocytes from patients with B-chronic lymphocytic leukemia (B-CLL) 
express large numbers of P2X7 receptors for extracellular adenosine 
triphosphate (ATP).  Activation of P2X7 receptors induces multiple downstream 
effects, of which the best documented is the opening of an ionic channel that is 
selective for divalent cations.  Another effect of ATP is to induce the shedding of 
L-selectin (CD62L), a molecule which is involved in the adhesive interactions of 
lymphocytes on endothelial cells.  High levels of soluble L-selectin and CD23 
are found in the serum of patients with B-CLL, although the mechanisms 
involved in their production are poorly characterized.  Because extracellular 
ATP causes shedding of L-selectin, we studied the effect of ATP on shedding of 
CD23, an adhesion molecule expressed on the surface of B-CLL lymphocytes.  
ATP induced the shedding of CD23 at an initial rate of 12% of that for L-
selectin, while the EC50 of ATP (35 µM) and BzATP (10 µM) was identical for 
shedding of both molecules.  Inactivation of the P2X7 receptor by pre-incubation 
with OxATP, an irreversible inhibitor of P2X7 purinoceptor, abolished ATP-
induced shedding of both molecules.  Moreover, KN-62, the most potent 
inhibitor for the P2X7 receptor inhibited ATP-induced shedding of both CD23 
and L-selectin with the same IC50 (12 nM).  Ro 31-9790, a membrane permeant 
zinc chelator which inhibits the phorbol-ester stimulated shedding of L-selectin  
also inhibited shedding of CD23 from B-CLL lymphocytes, but the IC50 was 
different for the two shed molecules (25 versus 1 µg/ml respectively). Although 
L-selectin was completely shed by incubation of cells with phorbol-ester no 
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CD23 was lost under these conditions. Also, Ca2+ inhibits ATP-induced CD23 
shedding but not L-selectin shedding.  
 
Since soluble CD23 and L-selectin are found in the serum of normal subjects 
and B-CLL patients, the expression of these two adhesion molecules on 
lymphocytes before and after transendothelial migration was studied in an in 
vitro model of this process.  In normal and B-CLL subjects, 71±5% of L-selectin 
from both T and B cells and 90% of CD23 from B cells was lost following 
transmigration, while the expression of a range of other adhesion molecules 
such as VLA-4, ICAM-1, LFA-1 and CD44 was unchanged.  Lymphocytes 
incubated with OxATP retained  their capacity for transendothelial migration and 
showed the same loss of L-selectin as control leukaemic lymphocytes.  Ro 31-
9790, which can protect ATP-induced both L-selectin and CD23 shedding, had 
no effect on inhibiting L-selectin and CD23 lost during transmigration.  These 
data show the presence of a second pathway for the downregulation of L-
selectin and CD23 from the lymphocyte surface. 
 
Data in vivo from 'knock-out' mice show that L-selectin is essential for the 
emigration of lymphocytes through high endothelial venules into lymph nodes. 
The migration of normal and B-CLL lymphocytes across confluent human 
umbilical vein endothelial monolayers was studied  in an in vitro model of this 
process.  Lymphocytes treated with ATP or BzATP showed 56±25% or 67±16% 
loss of L-selectin on the surface and 36±24% or 64±19% decrease of 
transmigration, respectively, while OxATP, which does not alter the L-selectin 
level, had no effect on lymphocyte transmigration.  Further experiments 
examined this correlation between L-selectin expression and lymphocyte 
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transendothelial migration in this model system.  A quantitative assay for cell 
surface L-selectin showed that expression of L-selectin was lower on B-CLL 
lymphocytes (8,880±5,700 molecules/cell) than on normal lymphocytes 
(29,500±7,500 molecules/cell, p<0.001).  Also the rate of transmigration of B-
CLL lymphocytes (1.5±0.9 migrated cells/HUVEC) was lower than normal 
peripheral lymphocytes (2.4±0.9 migrated cells/HUVEC, p=0.04).   Incubation of 
lymphocytes in complete medium for 24 hrs increased the expression of L-
selectin on B-CLL lymphocytes by 1.5 to 2 fold while the normal lymphocyte L-
selectin remained at the initial level.  This upregulation of B-CLL L-selectin 
correlated with a 2 fold increased rate of transendothelial migration.  A 
correlation was found between L-selectin expression on lymphocytes and their 
ability for  transendothelial migration (r2=0.6).   
 
This study shows that the adhesion molecules L-selectin and CD23 can be lost 
from lymphocytes by two different physiological pathways. One is by P2X7 
receptor activation by extracellular ATP while the second is activated by 
transendothelial migration of these cells.  A second finding is that B-CLL 
lymphocytes have lower level of L-selectin expression and an impaired ability for 
transendothelial migration compared with normal peripheral blood lymphocytes.  
Do these results explain the high serum levels of soluble L-selectin and CD23 
observed in B-CLL?  Although B-CLL lymphocytes do not recirculate as rapidly 
as normal peripheral blood lymphocytes, the greatly increased number of 
leukaemic cells in B-CLL ensures that much more soluble L-selectin and CD23 
is generated during the recirculation of these cells through the body.   
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ABBREVIATIONS 
 
The abbreviations listed below are frequently used in the thesis. 
 
µM  10-6 M 
ATP  adenosine 5'-triphosphate 
BAPTA-AM 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid tetrakis 
(acetoxymethyl ester) 
BSA  bovine serum albumin 
BzATP 3'-O-(4-benzoyl)benzoyl-adenosine 5'-triphosphate 
CLL  chronic lymphocytic leukemia 
dATP 3'-deoxy adenosine 5'-triphosphate 
EC50  concentration of a drug that produce 50% of the maximum 
response 
ECGS endothelial-cell growth supplement  
ECL  enhanced chemiluminescence 
EDTA  ethylenediaminetetraacetic acid 
EGTA  ethylene glycol-bis (ß-aminoethyl ether) N,N,N',N'-tetraacetic 
 acid 
ELISA  enzyme-linked immunosorbent assay 
Fig  figure 
FITC  fluorescein isothiocyanate 
Fura-2 AM Fura-2 acetoxymethyl ester 
HBSS Hanks balanced salt solution 
HEPES N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid 
HEV  high endothelial cells present in postcapillary venules 
HMA  5-(N,N-hexamethylene)-amiloride 
HRP  horseradish peroxidase 
HUVEC human umbilical vein endothelial cell 
IFN-γ Interferon-γ 
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KN-62  1-[N,O-bis(5-isoquinoline sulfonyl)N-methyl-L-tyrosyl]-4-
phenylpiperazine 
2-MeSATP 2-methylthio- adenosine 5'-triphosphate 
α,β-meATP α,β-methylene adenosine 5'-triphosphate 
MESF  molecules of equivalent soluble fluorescein 
mM  10-3 M 
MoAb  monoclonal antibody 
nM  10-9 M 
OxATP adenosine 5'-triphosphate-2',3'-dialdehyde 
PAGE polyacrylamide gel electrophoresis 
PBS  phosphate buffered saline 
PLD  phospholipase D 
PMA  phorbol 12-myristate 13-acetate 
PTX pertussis toxin 
Ro 31-9790 N-2-((2s)-[(hydroxycarbamoyl)4-methylvaleryl]-N-1,3-dimethyl-L-
valinamide 
R.T. room temperature 
SDS sodium dodecyl sulfate 
TMA  trimethylammonium chloride 
TNF-α Tumour Necrosis Factor-α 
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